EC Number   |
Disease  |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    3.1.2.12 | Acquired Immunodeficiency Syndrome |
1986686 |
Prevalence of Mycobacterium avium complex in respiratory specimens from AIDS and non-AIDS patients in a San Francisco hospital. |
diagnostic usage
ongoing research
unassigned |
1
2
0 |
| 3.1.2.12 | Acquired Immunodeficiency Syndrome |
2305441 |
Red cell transfusion therapy for anemia in patients with AIDS and ARC: incidence, associated factors, and outcome. |
causal interaction
unassigned |
2
0 |
| 3.1.2.12 | Acquired Immunodeficiency Syndrome |
2345428 |
Renal involvement in patients infected with HIV: experience at San Francisco General Hospital. |
diagnostic usage
ongoing research
unassigned |
1
2
0 |
| 3.1.2.12 | Acquired Immunodeficiency Syndrome |
3777686 |
Intensive care of patients with the acquired immunodeficiency syndrome. Outcome and changing patterns of utilization. |
causal interaction
therapeutic application
unassigned |
4
2
0 |
| 3.1.2.12 | Acquired Immunodeficiency Syndrome |
9735689 |
Splenomegaly in 2,505 patients at a large university medical center from 1913 to 1995. 1963 to 1995: 449 patients. |
causal interaction
diagnostic usage
unassigned |
1
2
0 |
| 3.1.2.12 | Acquired Immunodeficiency Syndrome |
23607844 |
A strange new disease in San Francisco:a brief history of the city and its response to the HIV/AIDS epidemic. |
unassigned |
0 |
| 3.1.2.12 | Adenocarcinoma of Lung |
21596165 |
Activity-based proteomics: Identification of ABHD11 and ESD activities as potential biomarkers for human lung adenocarcinoma. |
ongoing research
unassigned |
1
0 |
| 3.1.2.12 | Agranulocytosis |
10503166 |
A placebo-controlled trial of the immune modulator, lentinan, in HIV-positive patients: a phase I/II trial. |
causal interaction
therapeutic application
unassigned |
1
2
0 |
| 3.1.2.12 | Alzheimer Disease |
19717305 |
Synthesis of organophosphates with fluorine-containing leaving groups as serine esterase inhibitors with potential for Alzheimer disease therapeutics. |
causal interaction
therapeutic application
unassigned |
4
4
0 |
| 3.1.2.12 | Amyloidosis |
2068530 |
Fibril amyloid enhancing factor (FAEF)-accelerated amyloidosis in the hamster is not dependent on serine esterase activity and mononuclear phagocytosis. |
unassigned |
0 |
